Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
AquaBounty Technologies, Inc. focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered salmon for human consumption.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $127,663.00 | $1.2M | $3.1M | $2.5M | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$16.2M | -$22.1M | -$22.3M | -$13.7M | -$9.6M | -$4.0M |
| Net income | -$16.4M | -$22.3M | -$22.2M | -$27.6M | -$149.2M | -$18.5M |
| Diluted EPS | — | -$0.32 | -$5.78 | -$7.17 | -$38.65 | -$4.77 |
| Operating cash flow | -$14.3M | -$20.5M | -$21.0M | -$24.2M | -$13.9M | -$8.7M |
| Free cash flow | -$18.3M | -$26.2M | -$88.5M | -$93.1M | -$16.8M | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -12727.1% | -1883.0% | -711.6% | -552.9% | — | — |
| Net margin | -12846.3% | -1900.1% | -706.3% | -1114.5% | — | — |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $180,182.00 | $47,812.00 | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$29.6M | -$1.6M | $24.1M | -$1.2M | -$3.3M | -$1.5M | $1.9M | -$621,566.00 |
| Net income | -$50.5M | -$3.4M | -$84.1M | $401,135.00 | -$3.4M | -$1.4M | -$14.1M | -$1.2M |
| Diluted EPS | -$13.08 | -$0.88 | -$21.79 | $0.11 | -$0.87 | -$0.36 | -$3.65 | -$0.26 |
| Operating cash flow | -$4.3M | -$4.0M | -$1.1M | -$2.4M | -$1.5M | -$1.7M | -$3.2M | -$1.0M |
| Free cash flow | -$5.2M | -$4.7M | -$1.4M | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -16405.6% | -3380.5% | — | — | — | — | — | — |
| Net margin | -28035.1% | -7120.2% | — | — | — | — | — | — |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.